Literature DB >> 31204653

De-Escalation Strategies in HPV-Associated Oropharynx Cancer-Are we Putting the Cart Before the Horse?

Carryn M Anderson, Randall J Kimple, Alexander Lin, Sana D Karam, Danielle N Margalit, Melvin L K Chua.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31204653      PMCID： PMC7194352          DOI： 10.1016/j.ijrobp.2019.02.054

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  19 in total

1.  Human papillomavirus and survival of patients with oropharyngeal cancer.

Authors:  K Kian Ang; Jonathan Harris; Richard Wheeler; Randal Weber; David I Rosenthal; Phuc Felix Nguyen-Tân; William H Westra; Christine H Chung; Richard C Jordan; Charles Lu; Harold Kim; Rita Axelrod; C Craig Silverman; Kevin P Redmond; Maura L Gillison
Journal:  N Engl J Med       Date:  2010-06-07       Impact factor: 91.245

2.  Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study.

Authors:  Brian O'Sullivan; Shao Hui Huang; Jie Su; Adam S Garden; Erich M Sturgis; Kristina Dahlstrom; Nancy Lee; Nadeem Riaz; Xin Pei; Shlomo A Koyfman; David Adelstein; Brian B Burkey; Jeppe Friborg; Claus A Kristensen; Anita B Gothelf; Frank Hoebers; Bernd Kremer; Ernst-Jan Speel; Daniel W Bowles; David Raben; Sana D Karam; Eugene Yu; Wei Xu
Journal:  Lancet Oncol       Date:  2016-02-27       Impact factor: 41.316

3.  Mature results of a prospective study of deintensified chemoradiotherapy for low-risk human papillomavirus-associated oropharyngeal squamous cell carcinoma.

Authors:  Bhishamjit S Chera; Robert J Amdur; Joel E Tepper; Xianming Tan; Jared Weiss; Juneko E Grilley-Olson; D Neil Hayes; Adam Zanation; Trevor G Hackman; Samip Patel; Nathan Sheets; Mark C Weissler; William M Mendenhall
Journal:  Cancer       Date:  2018-03-26       Impact factor: 6.860

4.  Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis.

Authors:  Brian O'Sullivan; Shao Hui Huang; Lillian L Siu; John Waldron; Helen Zhao; Bayardo Perez-Ordonez; Ilan Weinreb; John Kim; Jolie Ringash; Andrew Bayley; Laura A Dawson; Andrew Hope; John Cho; Jonathan Irish; Ralph Gilbert; Patrick Gullane; Angela Hui; Fei-Fei Liu; Eric Chen; Wei Xu
Journal:  J Clin Oncol       Date:  2013-01-07       Impact factor: 44.544

5.  Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial.

Authors:  Jordi Giralt; Jose Trigo; Sandra Nuyts; Mahmut Ozsahin; Krzysztof Skladowski; Georges Hatoum; Jean-Francois Daisne; Alejandro César Yunes Ancona; Anthony Cmelak; Ricard Mesía; Alicia Zhang; Kelly S Oliner; Ari VanderWalde
Journal:  Lancet Oncol       Date:  2015-01-15       Impact factor: 41.316

6.  E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group.

Authors:  Shanthi Marur; Shuli Li; Anthony J Cmelak; Maura L Gillison; Weiqiang J Zhao; Robert L Ferris; William H Westra; Jill Gilbert; Julie E Bauman; Lynne I Wagner; David R Trevarthen; Jahagirdar Balkrishna; Barbara A Murphy; Nishant Agrawal; A Dimitrios Colevas; Christine H Chung; Barbara Burtness
Journal:  J Clin Oncol       Date:  2016-12-28       Impact factor: 44.544

7.  Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial.

Authors:  Stefano Maria Magrini; Michela Buglione; Renzo Corvò; Luigi Pirtoli; Fabiola Paiar; Pietro Ponticelli; Alessia Petrucci; Almalina Bacigalupo; Monica Crociani; Luciana Lastrucci; Stefania Vecchio; Pierluigi Bonomo; Nadia Pasinetti; Luca Triggiani; Roberta Cavagnini; Loredana Costa; Sandro Tonoli; Marta Maddalo; Salvatore Grisanti
Journal:  J Clin Oncol       Date:  2015-12-07       Impact factor: 44.544

8.  Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.

Authors:  James A Bonner; Paul M Harari; Jordi Giralt; Nozar Azarnia; Dong M Shin; Roger B Cohen; Christopher U Jones; Ranjan Sur; David Raben; Jacek Jassem; Roger Ove; Merrill S Kies; Jose Baselga; Hagop Youssoufian; Nadia Amellal; Eric K Rowinsky; K Kian Ang
Journal:  N Engl J Med       Date:  2006-02-09       Impact factor: 91.245

9.  Effect of Standard Radiotherapy With Cisplatin vs Accelerated Radiotherapy With Panitumumab in Locoregionally Advanced Squamous Cell Head and Neck Carcinoma: A Randomized Clinical Trial.

Authors:  Lillian L Siu; John N Waldron; Bingshu E Chen; Eric Winquist; Jim R Wright; Abdenour Nabid; John H Hay; Jolie Ringash; Geoffrey Liu; Ana Johnson; George Shenouda; Martin Chasen; Andrew Pearce; James B Butler; Stephen Breen; Eric Xueyu Chen; T J FitzGerald; T J Childs; Alexander Montenegro; Brian O'Sullivan; Wendy R Parulekar
Journal:  JAMA Oncol       Date:  2017-02-01       Impact factor: 31.777

10.  Survival, recurrence and toxicity of HNSCC in comparison of a radiotherapy combination with cisplatin versus cetuximab: a meta-analysis.

Authors:  Jingwen Huang; Jing Zhang; Changle Shi; Lei Liu; Yuquan Wei
Journal:  BMC Cancer       Date:  2016-08-26       Impact factor: 4.430
View more
  7 in total

Review 1.  Novel Strategies for Managing Retropharyngeal Lymph Node Metastases in Head and Neck and Thyroid Cancer with Transoral Robotic Surgery (TORS).

Authors:  George Garas; Nick J Roland; Jeffrey Lancaster; Matthew Zammit; Victoria A Manon; Katharine Davies; Terry M Jones; Mriganka De; Floyd C Holsinger; Robin J D Prestwich; Jason C Fleming
Journal:  Ann Surg Oncol       Date:  2022-07-16       Impact factor: 4.339

2.  Synergies Radiotherapy-Immunotherapy in Head and Neck Cancers. A New Concept for Radiotherapy Target Volumes-"Immunological Dose Painting".

Authors:  Camil Ciprian Mireştean; Anda Crişan; Călin Buzea; Roxana Irina Iancu; DragoşPetru Teodor Iancu
Journal:  Medicina (Kaunas)       Date:  2020-12-23       Impact factor: 2.430

Review 3.  Radiotherapy biobanking: current landscape, opportunities, challenges, and future aspirations.

Authors:  Tim H Ward; Duncan C Gilbert; George Higginbotham; Chris M Morris; Valerie Speirs; Nicola J Curtin
Journal:  J Pathol Clin Res       Date:  2021-10-17

Review 4.  Micro-RNAs, the Cornerstones of the Future of Radiobiology in Head and Neck Cancers?

Authors:  Camil Ciprian Mireștean; Roxana Irina Iancu; Dragoș Petru Teodor Iancu
Journal:  Curr Oncol       Date:  2022-02-02       Impact factor: 3.677

5.  The accuracy of clinical neck staging for p16-positive and negative oropharyngeal cancer and its therapeutic implications.

Authors:  Timon Hussain; Kruthika Thangavelu; Cornelius Kürten; Lisa Galland; Benedikt Höing; Eric Deuss; Stefan Mattheis; Stephan Lang; Cornelius Deuschl; Michael Forsting; Nils Dörner
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-07-04       Impact factor: 3.236

6.  Survival Outcomes and Treatment Decision by Human Papillomavirus Status Among Patients With Stage IVC Head and Neck Squamous Cell Carcinoma.

Authors:  Ping Zhou; Yi-Feng Yu; Chen-Lu Lian; Jun Wang; Ren-Gong Zhuo; San-Gang Wu
Journal:  Front Oncol       Date:  2021-05-31       Impact factor: 6.244

7.  Retropharyngeal Lymph Node Involvement in Oropharyngeal Carcinoma: Impact upon Risk of Distant Metastases and Survival Outcomes.

Authors:  Zsuzsanna Iyizoba-Ebozue; Louise J Murray; Moses Arunsingh; Karen E Dyker; Sriram Vaidyanathan; Andrew F Scarsbrook; Robin J D Prestwich
Journal:  Cancers (Basel)       Date:  2019-12-29       Impact factor: 6.639
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.